Welcome to our dedicated page for American Well news (Ticker: AMWL), a resource for investors and traders seeking the latest updates and insights on American Well stock.
American Well Corp (AMWL) is a leading telehealth platform enabling digital care solutions across healthcare ecosystems. This page serves as the definitive source for verified news and official announcements from the company, providing stakeholders with timely insights into strategic developments.
Access comprehensive updates including earnings reports, technology innovations, partnership announcements, and regulatory milestones. Investors and industry observers can track AMWL's progress in advancing hybrid care models and expanding its digital health infrastructure.
All content is curated to ensure relevance to AMWL's operations in virtual care delivery, platform enhancements, and collaborations with healthcare providers. Bookmark this page for efficient monitoring of the company's evolving role in shaping accessible, technology-driven healthcare solutions.
Amwell (NYSE: AMWL) has announced a deal to shorten the earnout period from its August 2021 acquisition of SilverCloud Health, a digital mental health company. This restructuring leads to the issuance of 4,959,856 shares of Class A common stock to SilverCloud's former stockholders. The move aims to expedite the integration of SilverCloud into Amwell’s platform, which Dr. Ido Schoenberg highlights as pivotal for enhancing cultural and operational efficiency in delivering behavioral health solutions. The partnership expects to address the significant demand in behavioral health care exacerbated by recent global events.
Amwell reported Q1 2022 revenue of $64.2 million, up from $57.6 million year-over-year. Gross margin improved to 42.8% from 38.0%. Active providers increased to ~102,000, and total visits rose to ~1.8 million. However, the net loss widened to ($70.3 million), compared to ($39.8 million) last year, while adjusted EBITDA was (47.1 million), up from (26.4 million). Amwell maintains its 2022 revenue guidance of $275 - $285 million.
Amwell (NYSE: AMWL) has appointed Susan Worthy as Chief Marketing Officer. With over 25 years in healthcare marketing, her role involves leading Amwell’s overall marketing strategy to enhance market position and shareholder value. Worthy previously led marketing at Optum, and her expertise is expected to drive growth during a transformative period for the company. She succeeds Mary Modahl, who retires after over a decade at Amwell. The company aims to improve healthcare access via technology and support over 80 million lives through its telehealth platform.
Amwell (NYSE: AMWL), a leader in telehealth, announced participation in key investor conferences. On May 11, 2022, Dr. Ido Schoenberg, CEO, and CFO Bob Shepardson will present at the BofA Healthcare Conference in Las Vegas. They will also participate in the RBC Capital Markets Healthcare Conference in New York City on May 17, 2022, at 2:05 p.m. ET, and at the Needham Virtual Tech and Media Conference on May 19, 2022, at 10:15 a.m. ET. Audio webcasts will be available on their investor relations website.
Amwell (NYSE: AMWL) has expanded its virtual specialty care offerings, introducing Musculoskeletal (MSK) and Dermatology programs. These initiatives cater to healthcare challenges affecting approximately 50% of U.S. adults, focusing on costly musculoskeletal conditions and the shortage of dermatologists. The MSK program aims to improve access to physical therapy and enhance treatment adherence through digital tools. Meanwhile, the Dermatology program provides quick access to care, reducing the average wait time for in-person visits from 35 days to 24 hours for diagnoses.
Amwell (NYSE: AMWL), a leader in telehealth, will report its first-quarter operating results for the period ending March 31, 2022, on May 9, 2022. Following the earnings release, the management team will host a live conference call at 5:00 p.m. ET to discuss results and provide a business update. Investors can access the webcast on the company's website and call in using provided numbers. Amwell connects providers and patients to enhance healthcare delivery, supporting over 80 million lives through partnerships with 2,000 hospitals and 55 health plans.
Amwell (NYSE: AMWL) has announced a shortened earnout period for its acquisition of Conversa Health, which was purchased in August 2021. This strategic move is expected to enhance integration and support new product development, cross-selling opportunities, and operational efficiencies. In coordination, Amwell issued 1,020,964 shares of Class A common stock to Conversa's former stockholders. Amwell's CEO emphasized the seamless integration as a key driver for improved care delivery and innovative healthcare solutions.
Amwell (NYSE: AMWL), a leader in telehealth, announced participation in upcoming investor conferences.
Key events include Cowen’s 42nd Annual Health Care Conference on March 8, 2022, and Keybanc’s Virtual Healthcare Conference on March 22, 2022. Executives Ido Schoenberg, Roy Schoenberg, and Robert Shepardson will represent the company.
Audio webcasts will be accessible on their investor relations website.
Amwell aims to transform healthcare through a comprehensive digital platform, serving over 80 million lives across 55 health plans.
Amwell (NYSE: AMWL) reported strong fourth quarter and full year results for 2021, with total revenue of $252.8 million and gross margins of 41%. The company achieved 1.5 million active visits in Q4, up from 1.4 million in Q3. Subscription revenue rose to $30.1 million, a significant increase from last year. Despite a net loss of ($47.9 million) in Q4, the company aims for revenue growth between $275 million and $285 million for 2022. The increased active providers reached approximately 91,000 indicates positive traction on their Converge platform.
Amwell (NYSE: AMWL), a leader in telehealth, will report its fourth quarter and full year results for the period ended December 31, 2021, on February 24, 2022. The management team will conduct a live conference call and webcast at 5:00 p.m. ET to discuss the results and provide a business update. Interested parties can access the webcast via the Company's Investors website or through a dedicated phone line. Amwell connects providers and patients, covering over 80 million lives and offering a comprehensive telehealth platform for various healthcare needs.
